CN118146096A - 2, 2-Dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative and preparation method thereof - Google Patents
2, 2-Dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative and preparation method thereof Download PDFInfo
- Publication number
- CN118146096A CN118146096A CN202311539955.XA CN202311539955A CN118146096A CN 118146096 A CN118146096 A CN 118146096A CN 202311539955 A CN202311539955 A CN 202311539955A CN 118146096 A CN118146096 A CN 118146096A
- Authority
- CN
- China
- Prior art keywords
- reaction
- sodium
- dimethyl
- chlorobenzyl
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 32
- DLPBZANLIRTMKU-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-2,2-dimethylcyclopentan-1-one Chemical class O=C1C(C)(C)CCC1CC1=CC=C(Cl)C=C1 DLPBZANLIRTMKU-UHFFFAOYSA-N 0.000 title claims abstract description 31
- 238000006243 chemical reaction Methods 0.000 claims abstract description 81
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 7
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 7
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 43
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 40
- -1 alkali metal alkoxide Chemical class 0.000 claims description 31
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 30
- 239000003960 organic solvent Substances 0.000 claims description 26
- 238000010992 reflux Methods 0.000 claims description 26
- FYGHSUNMUKGBRK-UHFFFAOYSA-N 1,2,3-trimethylbenzene Chemical compound CC1=CC=CC(C)=C1C FYGHSUNMUKGBRK-UHFFFAOYSA-N 0.000 claims description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 20
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 18
- 229910052783 alkali metal Inorganic materials 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 16
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 15
- 238000004817 gas chromatography Methods 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 13
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 12
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 claims description 12
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 12
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 12
- 239000012044 organic layer Substances 0.000 claims description 12
- 230000035484 reaction time Effects 0.000 claims description 12
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 claims description 12
- 239000008096 xylene Substances 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 11
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 10
- 230000007935 neutral effect Effects 0.000 claims description 10
- 238000010791 quenching Methods 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 10
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 9
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 9
- 229910052744 lithium Inorganic materials 0.000 claims description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 9
- 230000001105 regulatory effect Effects 0.000 claims description 9
- JQZAEUFPPSRDOP-UHFFFAOYSA-N 1-chloro-4-(chloromethyl)benzene Chemical compound ClCC1=CC=C(Cl)C=C1 JQZAEUFPPSRDOP-UHFFFAOYSA-N 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 8
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 8
- 229910052794 bromium Inorganic materials 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 8
- 238000004821 distillation Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 239000001301 oxygen Substances 0.000 claims description 8
- 229910052760 oxygen Inorganic materials 0.000 claims description 8
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- 239000012312 sodium hydride Substances 0.000 claims description 7
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 7
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 6
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical group [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 6
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical group [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 6
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims description 6
- 150000002510 isobutyric acid esters Chemical class 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 claims description 6
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical group [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 claims description 6
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 6
- WQKGAJDYBZOFSR-UHFFFAOYSA-N potassium;propan-2-olate Chemical compound [K+].CC(C)[O-] WQKGAJDYBZOFSR-UHFFFAOYSA-N 0.000 claims description 6
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 6
- WBQTXTBONIWRGK-UHFFFAOYSA-N sodium;propan-2-olate Chemical compound [Na+].CC(C)[O-] WBQTXTBONIWRGK-UHFFFAOYSA-N 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 238000006467 substitution reaction Methods 0.000 claims description 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- 229960000583 acetic acid Drugs 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 239000012362 glacial acetic acid Substances 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 229910052757 nitrogen Chemical group 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 150000004820 halides Chemical class 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 claims description 3
- 229910000103 lithium hydride Inorganic materials 0.000 claims description 3
- SZAVVKVUMPLRRS-UHFFFAOYSA-N lithium;propane Chemical compound [Li+].C[CH-]C SZAVVKVUMPLRRS-UHFFFAOYSA-N 0.000 claims description 3
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 3
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 claims description 3
- 229910017604 nitric acid Inorganic materials 0.000 claims description 3
- 239000003208 petroleum Substances 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 claims description 3
- 229910000105 potassium hydride Inorganic materials 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 230000002194 synthesizing effect Effects 0.000 claims description 3
- 238000010189 synthetic method Methods 0.000 claims description 3
- 229940070710 valerate Drugs 0.000 claims description 3
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 150000001408 amides Chemical class 0.000 claims description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000001979 organolithium group Chemical group 0.000 claims description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- 229910052708 sodium Inorganic materials 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- 125000003944 tolyl group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 239000005868 Metconazole Substances 0.000 abstract description 7
- XWPZUHJBOLQNMN-UHFFFAOYSA-N metconazole Chemical compound C1=NC=NN1CC1(O)C(C)(C)CCC1CC1=CC=C(Cl)C=C1 XWPZUHJBOLQNMN-UHFFFAOYSA-N 0.000 abstract description 7
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 abstract description 6
- 239000000575 pesticide Substances 0.000 abstract description 5
- 238000001308 synthesis method Methods 0.000 abstract description 5
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 4
- 238000004065 wastewater treatment Methods 0.000 abstract description 2
- 239000010410 layer Substances 0.000 description 11
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 10
- 239000000203 mixture Substances 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 5
- SPUCFJYSOOULRC-UHFFFAOYSA-N [Na].CC(C)CO Chemical compound [Na].CC(C)CO SPUCFJYSOOULRC-UHFFFAOYSA-N 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 5
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 3
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 3
- RXGUIWHIADMCFC-UHFFFAOYSA-N 2-Methylpropyl 2-methylpropionate Chemical compound CC(C)COC(=O)C(C)C RXGUIWHIADMCFC-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000000010 aprotic solvent Substances 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- BHIWKHZACMWKOJ-UHFFFAOYSA-N methyl isobutyrate Chemical compound COC(=O)C(C)C BHIWKHZACMWKOJ-UHFFFAOYSA-N 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- HJEZRYIJNHAIGY-UHFFFAOYSA-N tert-butyl 4-bromobutanoate Chemical compound CC(C)(C)OC(=O)CCCBr HJEZRYIJNHAIGY-UHFFFAOYSA-N 0.000 description 2
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 1
- HYOAGWAIGJXNQH-UHFFFAOYSA-N 1-bromo-1-chloropropane Chemical compound CCC(Cl)Br HYOAGWAIGJXNQH-UHFFFAOYSA-N 0.000 description 1
- FTGZMZBYOHMEPS-UHFFFAOYSA-N 2,2-dimethylcyclopentan-1-one Chemical class CC1(C)CCCC1=O FTGZMZBYOHMEPS-UHFFFAOYSA-N 0.000 description 1
- OTAIZHUTYHDXHP-UHFFFAOYSA-N 5-(4-chlorophenyl)-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol Chemical compound ClC1=CC=C(C=C1)C1CCC(C1(O)CN1N=CN=C1)(C)C OTAIZHUTYHDXHP-UHFFFAOYSA-N 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- VIZORQUEIQEFRT-UHFFFAOYSA-N Diethyl adipate Chemical compound CCOC(=O)CCCCC(=O)OCC VIZORQUEIQEFRT-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- LRUUNMYPIBZBQH-UHFFFAOYSA-N Methazole Chemical compound O=C1N(C)C(=O)ON1C1=CC=C(Cl)C(Cl)=C1 LRUUNMYPIBZBQH-UHFFFAOYSA-N 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000008686 ergosterol biosynthesis Effects 0.000 description 1
- XBPOBCXHALHJFP-UHFFFAOYSA-N ethyl 4-bromobutanoate Chemical compound CCOC(=O)CCCBr XBPOBCXHALHJFP-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- UWNADWZGEHDQAB-UHFFFAOYSA-N i-Pr2C2H4i-Pr2 Natural products CC(C)CCC(C)C UWNADWZGEHDQAB-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- WDAXFOBOLVPGLV-UHFFFAOYSA-N isobutyric acid ethyl ester Natural products CCOC(=O)C(C)C WDAXFOBOLVPGLV-UHFFFAOYSA-N 0.000 description 1
- LRDFRRGEGBBSRN-UHFFFAOYSA-N isobutyronitrile Chemical compound CC(C)C#N LRDFRRGEGBBSRN-UHFFFAOYSA-N 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- GQALPOWUSYCKFO-UHFFFAOYSA-N methyl 3,3-dimethyl-2-oxocyclopentane-1-carboxylate Chemical compound COC(=O)C1CCC(C)(C)C1=O GQALPOWUSYCKFO-UHFFFAOYSA-N 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 150000003852 triazoles Chemical group 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention belongs to the technical field of pesticide preparation, and particularly relates to a 2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative and a preparation method thereof, and application of the derivative and the derivative in synthesis of a bactericidal metconazole intermediate. The invention discloses a 2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative, which has a structural general formula shown in a formula IV: IV:
Description
Technical Field
The invention belongs to the technical field of pesticide preparation, and particularly relates to a2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative and a preparation method thereof, and application of the derivative and the derivative in synthesis of a bactericidal metconazole intermediate.
Background
Metconazole, also known as metconazole, chemical name: 5- (4-chlorophenyl) -2, 2-dimethyl-1- (1H-1, 2, 4-triazol-1-ylmethyl) cyclopentanol, common name: metazole. The product is triazole bactericide developed by the chemical company of Wuluping in Japan in the 90 th century, and is an ergosterol synthesis inhibitor. The metconazole has the characteristics of novel structure, wide sterilization spectrum, high systemic property, low toxicity to non-target organisms, high sterilization activity and the like, and has the protection and treatment effects. Is mainly used for preventing and treating wheat scab, leaf rust, corn rust, soybean rust, rapeseed sclerotium disease and the like, and has wide market application prospect.
2, 2-Dimethyl-5- (4-chlorobenzyl) cyclopentanone is taken as an important intermediate for synthesizing metconazole, cyclopentanone (Res. Chem. Intermediate. 2017,43, 6293-6298) or diethyl adipate (pesticide, 2017,56,478-479; pesticide, 2012,51,413-415; pesticide, 2019,58 (11): 792-795) is taken as a starting material, the synthesis steps are long, multiple methylation is needed, and the synthesis process cost is high; US 6344580B1 uses isobutyronitrile as a starting material, a metallic lithium reagent is used for reacting with bromochloropropane, and sodium cyanide is substituted to obtain a key intermediate 2, 2-dimethyl dinitrile, but the use condition of the lithium reagent in the reaction process is severe, and certain safety, environmental and management hidden hazards exist in the use of sodium cyanide, and the reaction formula is as follows:
The patent CN 107365262B and the patent CN 112592275A take isobutyrate as raw materials, sodium cyanide is still required to be used in the second reaction, production safety and management risks exist, and the disposal of sodium cyanide-containing wastewater brought by production is troublesome, and the reaction formula is as follows:
Disclosure of Invention
The invention aims to provide a2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative and a preparation method thereof.
In order to solve the problems, the invention provides a 2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative, which has a structural general formula shown in a formula IV:
IV:
R is a C1-C6 alkyl substituent or hydrogen;
x is oxygen (R is C1-C6 alkyl substituent), nitrogen (R is hydrogen);
The alkyl is a linear or branched alkyl; the alkyl group itself or as part of another substituent is selected from methyl, ethyl, propyl, butyl, pentyl, hexyl and isomers thereof, the isomers thereof preferably being selected from isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl or tert-pentyl and the like.
As an improvement of the 2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative IV of the present invention, R is preferably: methyl, isopropyl, isobutyl, tert-butyl; x is preferably: oxygen.
The invention also provides a synthetic method of the 2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative IV, which comprises the following specific routes:
Wherein R 1 and R represent saturated or unsaturated alkyl substituents; r 1 is a C1-C6 alkyl substituent, preferably methyl, isopropyl, isobutyl, tert-butyl; r is a C1-C6 alkyl substituent or hydrogen, preferably: methyl, isopropyl, isobutyl, tert-butyl; x is oxygen, nitrogen, preferably oxygen; l is chlorine, bromine, iodine, preferably bromine.
The method comprises the following steps:
A. preparation of intermediate II:
under the low temperature condition, dissolving a raw material isobutyric acid ester derivative I in an anhydrous aprotic organic solvent to obtain a raw material solution; dropwise adding an organic lithium reagent into the solution I, and stirring at a constant temperature; dropwise adding a halogenated compound (VI) and carrying out substitution reaction under the heat preservation condition; post-treating the reaction product to obtain intermediate valerate II;
the reaction temperature of the substitution reaction is-40-0 ℃; the reaction time is 1-5 hours;
the aprotic organic solvent is selected from petroleum ether, n-hexane, cyclohexane, diethyl ether, 1, 2-dimethoxyethane, tetrahydrofuran or 2-methyltetrahydrofuran;
the organic lithium reagent is selected from butyl lithium, isopropyl lithium, methyl lithium, diisopropyl lithium amide or di (trimethylsilyl) lithium amide and the like;
R 1 is a C1-C6 alkyl substituent; preferably, it is: methyl, isopropyl, isobutyl, tert-butyl;
l is halogen chlorine, bromine or iodine; preferably, it is: bromine;
x, R are defined above, preferably substituents are defined above;
The molar ratio of the dosage of the isobutyric acid ester derivative I to the organic lithium reagent is 1:1.1-2.2; the molar ratio of the dosage of the isobutyric acid ester derivative I to the halide is 1:0.9-2.1;
B. preparation of intermediate III:
Dissolving the intermediate II in an aprotic organic solvent, adding alkali metal alkoxide, and heating and refluxing for reaction (the temperature of the heating reaction is preferably 60-130 ℃), wherein low-boiling-point substances are removed during the refluxing reaction; after the reflux reaction is finished, carrying out post-treatment to obtain a compound III;
the reaction time is 0.5-10 hours; the molar ratio of the using amount of the intermediate II to the alkali metal alkoxide is 1:1.1-2.2;
The aprotic organic solvent is selected from acetone, toluene, ethylbenzene, xylene, trimethylbenzene, ethylene glycol dimethyl ether, dioxane, dimethylformamide, dimethylacetamide, N-methylpyrrolidone, tetrahydrofuran, 2-methyltetrahydrofuran and the like, and preferably toluene, xylene, trimethylbenzene, ethylene glycol dimethyl ether, dioxane, tetrahydrofuran or 2-methyltetrahydrofuran and the like; the alkali metal alkoxide is selected from potassium methoxide, potassium ethoxide, potassium isopropoxide, potassium tert-butoxide, sodium methoxide, sodium ethoxide, sodium isopropoxide, sodium isobutanol, sodium tert-butoxide and the like;
x, R are defined as above, preferably substituents are defined as above;
C. Preparation of intermediate IV:
dissolving the intermediate III in an aprotic organic solvent, and adding alkali metal salt to react for 1+/-0.2 hours at the temperature of 100-130 ℃; then dropwise adding 4-chlorobenzyl chloride, heating and refluxing (the reaction temperature is preferably 50-120 ℃), removing low-boiling-point substances during the refluxing reaction, and carrying out aftertreatment after the refluxing reaction is finished to obtain an intermediate IV;
the heating reflux reaction time is 0.5-15 hours; the molar ratio of the using amount of the intermediate III to the alkali metal salt is 1:1.05-2.3; the mol ratio of the using amount of the intermediate III to the 4-chlorobenzyl chloride is 1:0.9-1.3;
The aprotic organic solvent is selected from acetone, toluene, ethylbenzene, xylene, trimethylbenzene, ethylene glycol dimethyl ether, dioxane, dimethylformamide, dimethylacetamide, N-methylpyrrolidone, tetrahydrofuran, 2-methyltetrahydrofuran and the like, and preferably toluene, xylene, trimethylbenzene, ethylene glycol dimethyl ether, dioxane, tetrahydrofuran or 2-methyltetrahydrofuran and the like; the alkali metal salt is selected from sodium carbonate, potassium carbonate, sodium hydride, potassium methoxide, potassium ethoxide, potassium isopropoxide, potassium tert-butoxide, sodium methoxide, sodium ethoxide, sodium isopropoxide, sodium isobutanol, sodium tert-butoxide, sodium hydride, potassium hydride or lithium hydride, etc.
As an improvement of the synthetic method of the 2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative IV of the present invention:
In the step A: monitoring the progress of the reaction by Gas Chromatography (GC);
the post-treatment of the step A is as follows: after the reaction is finished, adding water to quench the reaction, regulating the pH to be neutral by dilute hydrochloric acid, layering, and recovering the aprotic organic solvent from the organic layer by reduced pressure distillation to obtain a product II;
The post-treatment of the step B is as follows: cooling to room temperature after the reaction is completed, adding water to quench the reaction, regulating the pH to be neutral by dilute hydrochloric acid, layering, and distilling an organic layer under reduced pressure to recover a solvent to obtain a compound III;
The post-treatment of the step C is as follows: cooling to room temperature after the reaction is completed, adding water to quench the reaction, layering, and distilling the organic layer under reduced pressure to recover the solvent to obtain an intermediate IV.
The invention also provides a synthesis method of the 2, 2-dimethyl-5- (4-chlor-yl) cyclopentanone (V), which utilizes the 2, 2-dimethyl-5- (4-chlorbenzyl) cyclopentanone derivative IV,
The reaction route is as follows:
preparation of intermediate V:
Dissolving the intermediate IV in mixed acid, heating and refluxing (the reaction temperature is preferably 40-120 ℃), and carrying out post-treatment after the reaction is finished to obtain a target product V;
The heating reflux reaction time is 0.5-10 hours; the mixed acid is at least one of glacial acetic acid, hydrochloric acid, sulfuric acid, trifluoroacetic acid, nitric acid, hydrobromic acid, phosphoric acid, methanesulfonic acid and p-toluenesulfonic acid (one or more mixed acids with the concentration of 10-100 percent can be selected), and the dosage of the mixed acid is 0.5-20 times of the mole of the intermediate IV.
The invention develops a synthetic route of 2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative, namely 2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone intermediate through a large number of experiments and scheme optimization based on earlier stage research and route exploration.
The synthesis method of the invention can reduce the production cost, simplify the reaction route, improve the preparation efficiency, avoid the production, environment and management risks brought by the use of sodium cyanide, reduce the wastewater treatment risks and steps, and lead the industrialized production and the operation to be simpler and more convenient.
Specifically, the synthesis method of the 2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative (IV) comprises the following steps:
A. preparation of Compound II:
Under the protection of N 2 gas, cooling to low temperature, dissolving isobutyrate (I) in anhydrous aprotic solvent, dropwise adding an organic lithium reagent into the solution of I, and stirring under heat preservation; then adding the halogenated compound (VI) dropwise, and reacting at a constant temperature. Monitoring the reaction progress by utilizing Gas Chromatography (GC), adding water to quench after the raw materials are reacted, regulating the pH to be neutral by dilute hydrochloric acid, layering, recovering an aprotic solvent by reduced pressure distillation of an organic layer, and obtaining a product II by reduced pressure distillation;
The reaction temperature of the substitution reaction is-78-0 ℃, preferably-40-0 ℃; the reaction time is 1 to 20 hours, preferably 1 to 5 hours; the aprotic organic solvent is preferably selected from petroleum ether, n-hexane, cyclohexane, diethyl ether, 1, 2-dimethoxyethane, tetrahydrofuran or 2-methyltetrahydrofuran, etc.; the organolithium reagent is preferably selected from butyllithium, isopropyllithium, methyllithium, diisopropyllithium amide, lithium bis (trimethylsilyl) amide, and the like; r 1 and R are C1-C6 alkyl substituents, preferably methyl, ethyl, isopropyl, n-butyl, isobutyl, tert-butyl; x is oxygen, nitrogen, preferably oxygen; l is selected from halogen chlorine, bromine, iodine, preferably bromine; the molar ratio of the dosage of the isobutyrate (I) to the organic lithium reagent is 1:1.1-2.2; the molar ratio of the amount of the I to the halide is 1:0.9-2.1.
B. Preparation of Compound III:
dissolving II in an aprotic organic solvent, adding alkali metal alkoxide, heating and refluxing, removing low-boiling substances during the reflux, cooling after the reaction is completed, adding water for quenching reaction, regulating pH to be neutral by dilute hydrochloric acid, layering, and distilling an organic layer under reduced pressure to recover the solvent to obtain a compound III;
The reaction temperature of the ring closing reaction is 20-220 ℃, preferably 60-130 ℃; the reaction time is 0.5 to 10 hours, preferably 2 to 8 hours; the aprotic organic solvent is selected from acetone, toluene, ethylbenzene, xylene, trimethylbenzene, ethylene glycol dimethyl ether, dioxane, dimethylformamide, dimethylacetamide, N-methylpyrrolidone, tetrahydrofuran, 2-methyltetrahydrofuran and the like, and preferably toluene, xylene, trimethylbenzene, ethylene glycol dimethyl ether, dioxane, tetrahydrofuran or 2-methyltetrahydrofuran and the like; the alkali metal alkoxide is selected from potassium methoxide, potassium ethoxide, potassium isopropoxide, potassium tert-butoxide, sodium methoxide, sodium ethoxide, sodium isopropoxide, sodium isobutanol, sodium tert-butoxide and the like; further, the molar ratio of the amount of II to the alkali metal alkoxide is 1:1.1-2.2.
C. preparation of Compound IV:
Dissolving III in an aprotic organic solvent, adding alkali metal salt, dropwise adding 4-chlorobenzyl chloride, heating and refluxing, removing low-boiling substances during the process, cooling after the reaction is completed, adding water for quenching reaction, layering, and distilling an organic layer under reduced pressure to recover the solvent to obtain a target substance IV;
The reaction temperature of the reaction is 20-150 ℃, preferably 50-120 ℃; the reaction time is 0.5 to 15 hours, preferably 2 to 8 hours; the aprotic organic solvent is selected from acetone, toluene, ethylbenzene, xylene, trimethylbenzene, ethylene glycol dimethyl ether, dioxane, dimethylformamide, dimethylacetamide, N-methylpyrrolidone, tetrahydrofuran, 2-methyltetrahydrofuran and the like, and preferably toluene, xylene, trimethylbenzene, ethylene glycol dimethyl ether, dioxane, tetrahydrofuran or 2-methyltetrahydrofuran and the like; the alkali metal salt is selected from sodium carbonate, potassium carbonate, sodium hydride, potassium methoxide, potassium ethoxide, potassium isopropoxide, potassium tert-butoxide, sodium methoxide, sodium ethoxide, sodium isopropoxide, sodium isobutanol, sodium tert-butoxide, sodium hydride, potassium hydride or lithium hydride, etc.; further, the molar ratio of the usage amount of III to alkali metal salt is 1:1.05-2.3; the mol ratio of the dosage of III to the 4-chlorobenzyl chloride is 1:0.9-1.3.
Use of compounds of formula (IV) for the synthesis of 2, 2-dimethyl-5- (4-chloro) cyclopentanone (V)
Dissolving IV in mixed acid, heating and refluxing, cooling after the reaction is completed, adding water to quench the reaction, layering, and distilling an organic layer under reduced pressure to recover a solvent to obtain a compound V;
The reaction temperature of the reaction is 50-200 ℃, preferably 60-140 ℃; the reaction time is 0.5 to 10 hours, preferably 2 to 8 hours; the mixed acid is preferably glacial acetic acid, hydrochloric acid, sulfuric acid, trifluoroacetic acid, nitric acid, hydrobromic acid, phosphoric acid, methanesulfonic acid, p-toluenesulfonic acid and the like or one or more mixed acids thereof; the concentration of the mixed acid can be 10% -100%, preferably 20% -80%, and the acid dosage is generally 0.5-20 times, preferably 1-10 times of the IV molar ratio.
The invention has the following beneficial effects:
Firstly, compared with the background technology, the content of the obtained 2, 2-dimethyl-5- (4-chlor) cyclopentanone derivative (IV) is more than or equal to 95 percent, and the method can be directly used for synthesizing a bactericide metconazole intermediate (V), and provides an alternative scheme for safely preparing the 2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone (V). Secondly, the preparation method of the invention obtains the key intermediate 2, 2-dimethyl-cyclopentanone derivative in two steps, shortens the reaction steps and improves the preparation efficiency. Thirdly, cyanide with safety hazard is avoided in the reaction process, and the safety of production, environment and management is improved. Fourth, the preparation method provided by the invention is suitable for industrial mass production and has good economic benefit.
Detailed Description
The invention will be further described with reference to specific examples, but the scope of the invention is not limited thereto.
Example 1 preparation of intermediate valerate ii:
scheme 1.1 preparation of 6- (tert-butyl) 1-isobutyl 2, 2-dimethyl adipate
Under the protection of N 2 gas, 14.4 g (100 mmol) of isobutyl isobutyrate is dissolved in a three-neck round bottom flask which is filled with 80 mL of anhydrous tetrahydrofuran and 250mL of tetrahydrofuran, the mixture is cooled to-20 ℃ and evenly stirred, 55 mL (110 mmol) of N-hexane solution of lithium diisopropylamide is dropwise added into the system in 30-60 minutes, and the mixture is subjected to heat preservation reaction for 0.5 hour at-20 ℃;23 g (105 mmol) of tert-butyl 4-bromobutyrate was then added dropwise over 15-30 minutes, and the reaction was continued at-20℃for 2 hours after completion of the dropwise addition.
At this time, the GC monitors the reaction progress to find that the raw materials are completely reacted, 50 g of water is dripped into the reaction kettle, the pH is adjusted to be neutral by 2M hydrochloric acid, the reaction kettle is layered, and after the solvent (tetrahydrofuran and n-hexane) is recovered by normal pressure distillation of an upper organic layer, 26 g of 2, 2-dimethyl adipic acid 6- (tert-butyl) 1-isobutyl ester is obtained by reduced pressure distillation, and the yield is 92%.
The gas phase detection method comprises the following steps: sample inlet temperature: 250 ℃; the FID detector temperature is 250 ℃; capillary column SE-54; programming temperature: the temperature was maintained at 50℃for 1 minute, after which the temperature was raised to 240℃at a rate of 15℃per minute, and maintained at 240℃for 6 minutes.
Scheme 1.2 preparation of 6- (tert-butyl) 1-methyl 2, 2-dimethyl adipate
Under the protection of N 2 gas, 14 g (137 mmol) of methyl isobutyrate is dissolved in a three-neck round bottom flask which is filled with 80 mL of anhydrous tetrahydrofuran and 250mL of three-neck round bottom flask, cooled to-20 ℃ and evenly stirred, 75 mL (150 mmol) of N-hexane solution of lithium diisopropylamide is added dropwise in 15-30 minutes, and the mixture is reacted for 0.5 hour at-20 ℃; 28 g (130 mmol) of tert-butyl 4-bromobutyrate was added dropwise over 15-30 min, and the reaction was continued at-20℃for 2 hours after completion of the dropwise addition.
At this time, the GC monitors the reaction progress to find that the raw materials are completely reacted, 50 g of water is dripped into the reaction kettle, the pH is regulated to be neutral by 2M hydrochloric acid, the reaction kettle is layered, the organic layer is distilled under normal pressure to recover the solvent, and then the reduced pressure distillation is carried out to obtain 30.4 g of the product 2, 2-dimethyl adipic acid 6- (tert-butyl) 1-methyl ester, the yield is obtained 91%.1H NMR(400MHz,CDCl3)δ3.65(s,1H),2.18(m,2H),1.51(m,4H),1.43(s,9H),1.17(d,J=2.9Hz,6H).
Example 2 preparation of intermediate III:
scheme 2.1 preparation of 3, 3-dimethyl-2-oxocyclopentane-1-carboxylic acid methyl ester
10 G (50 mmol) of dimethyl 2, 2-dimethyl adipate was dissolved in a 250 ml round bottom flask containing 150ml of toluene, 2.8g (54 mmol) of sodium methoxide was added, the temperature was raised to 100 to 130℃and the reaction was heated to reflux for 5 hours, during which low boiling substances were removed (i.e., during the reflux, the low boiling substances were discharged from the reaction system from the water separator). GC detects that the raw material (namely, the intermediate (II)) is less than or equal to 2 percent, the reaction is cooled to room temperature after the completion of the reaction, 50 milliliters of water is added, the pH value is regulated to be neutral by 2M hydrochloric acid, the layers are separated, the organic solvent positioned at the upper layer is distilled and recovered under reduced pressure, and the remainder is 7.2 grams of 3, 3-dimethyl-2-oxo cyclopentane-1-methyl formate, and the yield is 86%.1H NMR(400MHz,CDCl3)δ3.74(s,3H),3.26(t,J=9.1Hz,1H),2.39–2.11(m,2H),1.99–1.68(m,3H),1.09(s,3H),1.08(s,3H).
Example 2.2 3, 3-dimethyl-2-oxocyclopentane-1-carboxylic acid isobutyl ester
14.3 G (50 mmol) of diisobutyl 2, 2-dimethylbenzoate are dissolved in a 150 ml round-bottomed flask containing 50 ml of toluene, 5.3g (55 mmol) of sodium isobutanol are added, the temperature is raised to 100-130℃and the reaction is carried out under reflux for 6 hours, during which time the low boilers are removed. GC detects that the raw material is less than or equal to 2 percent, the reaction is cooled to room temperature after the completion, 50 milliliters of water is added, the pH value is regulated to be neutral by 2M hydrochloric acid, the layers are separated, the organic solvent positioned at the upper layer is distilled and recovered under reduced pressure, and the remainder is 8.8 grams of 3, 3-dimethyl-2-oxo cyclopentane-1-isobutyl formate, and the yield is 83%.1H NMR(400MHz,CDCl3)δ3.96–3.81(m,2H),3.22(t,J=9.0Hz,1H),2.32–2.13(m,2H),2.02–1.85(m,2H),1.82–1.63(m,1H),1.06(s,3H),1.05(s,3H),0.90(d,J=6.8Hz,6H).
Example 3 preparation of intermediate IV:
Scheme 3.1 preparation of 1- (4-chlorobenzyl) -3, 3-dimethyl-2-oxocyclopentane-1-carboxylic acid isobutyl ester
21 G (100 mmol) of 3, 3-dimethyl-2-oxocyclopentane-1-carboxylic acid isobutyl ester were dissolved in a 250 ml round bottom flask containing 150 ml of toluene, 6.5g (120 mmol) of sodium methoxide was added, the temperature was raised to 100-130℃and the reaction was carried out for 1 hour, 16g (100 mmol) of 4-chlorobenzyl chloride was added dropwise over 15-30 minutes and the reaction was heated under reflux for 4 hours. GC detects that the raw material (the intermediate (III)) is less than or equal to 2 percent, the reaction is cooled to room temperature after the completion, 50 milliliters of water is added, the layers are separated, the organic solvent positioned at the upper layer is distilled and recovered under reduced pressure, and the remainder is 29 grams of 1- (4-chlorobenzyl) -3, 3-dimethyl-2-oxo cyclopentane-1-carboxylic acid isobutyl ester, and the yield is 88 percent.
Scheme 3.2 preparation of 1- (4-chlorobenzyl) -3, 3-dimethyl-2-oxocyclopentane-1-carboxylic acid isobutyl ester
21 G (100 mmol) of isobutyl 3, 3-dimethyl-2-oxocyclopentane-1-carboxylate are dissolved in a 250 ml round bottom flask containing 75 ml of tetrahydrofuran, 5g (130 mmol) of sodium hydride are added in portions at 0℃and the reaction is carried out for 0.5 h at room temperature, 19g (120 mmol) of 4-chlorobenzyl chloride are added dropwise over 15-30 min, the temperature is raised to 40-70℃and the reflux reaction is carried out for 10 h. GC detects that the raw material (the intermediate (III)) is less than or equal to 5 percent, the reaction is cooled to room temperature after the completion, 80 milliliters of water is added, the layers are separated, the organic solvent positioned at the upper layer is distilled and recovered under reduced pressure, and the remainder is 33 grams of 1- (4-chlorobenzyl) -3, 3-dimethyl-2-oxo cyclopentane-1-carboxylic acid isobutyl ester, and the yield is 91 percent (area normalization) ).1H NMR(400MHz,CDCl3)δ7.21(d,J=7.4Hz,2H),7.06(d,J=7.7Hz,2H),3.89(d,J=6.4Hz,2H),3.13(s,2H),2.35–2.26(m,1H),2.00–1.74(m,3H),1.50–1.38(m,1H),1.09(s,3H),0.91(d,J=6.7Hz,6H),0.68(s,3H).
Example 4 preparation of intermediate V:
34 g (100 mmol) of 1- (4-chlorobenzyl) -3, 3-dimethyl-2-oxocyclopentane-1-carboxylic acid isobutyl ester was dissolved in a mixed acid solution containing 120 ml of glacial acetic acid and 50ml of 12.5% concentrated sulfuric acid, and the temperature was raised to 90-120℃and the reaction was heated under reflux for 10 hours. GC detects that the raw material (the Intermediate (IV)) is less than or equal to 5 percent, the reaction is cooled to room temperature after completion, the reaction is poured into 150 milliliters of ice water, 150 milliliters of ethyl acetate is added, the layers are separated, the organic solvent positioned on the upper layer is distilled and recovered under reduced pressure, and the remainder is 22 grams of 2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone, and the yield is 93%.1H NMR(400MHz,CDCl3)δ7.23(d,J=8.4Hz,2H),7.09(d,J=8.4Hz,2H),3.06(dd,J=13.8,4.4Hz,1H),2.62(dd,J=13.9,8.7Hz,1H),2.47–2.39(m,1H),1.99–1.49(m,4H),1.08(s,3H),0.86(s,3H).
Example 5
19.4 G (0.24 mol) of hydrogen bromide gas was slowly introduced into a 100 ml round bottom flask containing 17.2 g (0.2 mol) of gamma-butyrolactone at room temperature, and the temperature was raised to 40℃and the reaction was stirred for 1 hour; 9.8 g (0.21 mol) of absolute ethanol was added and the reaction stirred for 4 hours. GC detects that the raw material is less than or equal to 2 percent, the reaction is cooled to room temperature after the completion, 50 milliliters of water is added, the mixture is fully oscillated, the mixture is stood for layering, the organic phase at the lower layer is washed by saturated sodium bicarbonate solution, the mixture is stood for layering, the lower organic phase is taken for reduced pressure distillation to recover the solvent, the remainder is 35 grams of ethyl 4-bromobutyrate, and the yield is 93.5 percent.
The above examples are preferred embodiments of the present invention, but the embodiments of the present invention are not limited to the above examples, and any other changes, modifications, substitutions, combinations, and simplifications that do not depart from the spirit and principle of the present invention should be made in the equivalent manner, and the embodiments are included in the protection scope of the present invention.
Claims (6)
1. A2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative characterized in that: has a structural general formula shown in a formula IV:
R is a C1-C6 alkyl substituent or hydrogen;
X is oxygen or nitrogen;
The alkyl is a linear or branched alkyl; the alkyl group itself or as part of another substituent is selected from methyl, ethyl, propyl, butyl, pentyl, hexyl and isomers thereof selected from isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl or tert-pentyl.
2. 2, 2-Dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative according to claim 1, characterized in that: r is preferably: methyl, isopropyl, isobutyl, tert-butyl; x is preferably: oxygen.
3. A process for the synthesis of 2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone derivatives according to claim 1 or 2, characterized in that:
The route is as follows:
The method comprises the following steps:
A. preparation of intermediate II:
under the low temperature condition, dissolving a raw material isobutyric acid ester derivative I in an anhydrous aprotic organic solvent to obtain a raw material solution; dropwise adding an organic lithium reagent into the solution I, and stirring at a constant temperature; dropwise adding a halogenated compound (VI) and carrying out substitution reaction under the heat preservation condition; post-treating the reaction product to obtain intermediate valerate II;
the reaction temperature of the substitution reaction is-40-0 ℃; the reaction time is 1-5 hours;
the aprotic organic solvent is selected from petroleum ether, n-hexane, cyclohexane, diethyl ether, 1, 2-dimethoxyethane, tetrahydrofuran or 2-methyltetrahydrofuran;
The organolithium reagent is selected from butyllithium, isopropyllithium, methyllithium, diisopropyllithium amide or lithium bis (trimethylsilyl) amide;
R 1 is a C1-C6 alkyl substituent;
L is halogen chlorine, bromine or iodine;
x, R is defined in claim 1,
The molar ratio of the dosage of the isobutyric acid ester derivative I to the organic lithium reagent is 1:1.1-2.2; the molar ratio of the dosage of the isobutyric acid ester derivative I to the halide is 1:0.9-2.1;
B. preparation of intermediate III:
dissolving the intermediate II in an aprotic organic solvent, adding alkali metal alkoxide, heating and refluxing for reaction, and removing low-boiling substances during the refluxing reaction; after the reflux reaction is finished, carrying out post-treatment to obtain a compound III;
the reaction time is 0.5-10 hours; the molar ratio of the using amount of the intermediate II to the alkali metal alkoxide is 1:1.1-2.2;
The aprotic organic solvent is selected from acetone, toluene, ethylbenzene, xylene, trimethylbenzene, ethylene glycol dimethyl ether, dioxane, dimethylformamide, dimethylacetamide, N-methylpyrrolidone, tetrahydrofuran and 2-methyltetrahydrofuran, and the alkali metal alkoxide is selected from potassium methoxide, potassium ethoxide, potassium isopropoxide, potassium tert-butoxide, sodium methoxide, sodium ethoxide, sodium isopropoxide, sodium isobutanoxide or sodium tert-butoxide;
X, R is defined in claim 1;
C. Preparation of intermediate IV:
Dissolving the intermediate III in an aprotic organic solvent, and adding alkali metal salt to react for 1+/-0.2 hours at the temperature of 100-130 ℃; then dropwise adding 4-chlorobenzyl chloride, heating and refluxing, removing low-boiling substances during the reflux reaction, and performing post-treatment after the reflux reaction is completed to obtain an intermediate IV;
The reaction time is 0.5-15 hours; the molar ratio of the using amount of the intermediate III to the alkali metal salt is 1:1.05-2.3; the mol ratio of the using amount of the intermediate III to the 4-chlorobenzyl chloride is 1:0.9-1.3;
The aprotic organic solvent is selected from acetone, toluene, ethylbenzene, xylene, trimethylbenzene, ethylene glycol dimethyl ether, dioxane, dimethylformamide, dimethylacetamide, N-methylpyrrolidone, tetrahydrofuran and 2-methyltetrahydrofuran, and the alkali metal salt is selected from sodium carbonate, potassium carbonate, sodium hydride, potassium methoxide, potassium ethoxide, potassium isopropoxide, potassium tert-butoxide, sodium methoxide, sodium ethoxide, sodium isopropoxide, sodium isobutanoxide, sodium tert-butoxide, sodium hydride, potassium hydride or lithium hydride.
4. A process for the synthesis of 2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative IV according to claim 3, characterized in that:
In step A: r 1 is preferably: methyl, isopropyl, isobutyl, tert-butyl; l is preferably: bromine; x, R preferred substituents are as defined in claim 2;
in step B: the aprotic organic solvent is preferably toluene, xylene, trimethylbenzene, ethylene glycol dimethyl ether, dioxane, tetrahydrofuran or 2-methyltetrahydrofuran; x, R preferred substituents are as defined in claim 2;
In step C: the aprotic organic solvent is preferably toluene, xylene, trimethylbenzene, ethylene glycol dimethyl ether, dioxane, tetrahydrofuran or 2-methyltetrahydrofuran.
5. The method for synthesizing 2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative IV according to claim 3 or 4, characterized in that:
In the step A: monitoring the progress of the reaction by Gas Chromatography (GC);
the post-treatment of the step A is as follows: after the reaction is finished, adding water to quench the reaction, regulating the pH to be neutral by dilute hydrochloric acid, layering, and recovering the aprotic organic solvent from the organic layer by reduced pressure distillation to obtain a product II;
The post-treatment of the step B is as follows: cooling to room temperature after the reaction is completed, adding water to quench the reaction, regulating the pH to be neutral by dilute hydrochloric acid, layering, and distilling an organic layer under reduced pressure to recover a solvent to obtain a compound III;
The post-treatment of the step C is as follows: cooling to room temperature after the reaction is completed, adding water to quench the reaction, layering, and distilling the organic layer under reduced pressure to recover the solvent to obtain an intermediate IV.
The synthetic method of 6.2,2-dimethyl-5- (4-chloro) cyclopentanone (V) is characterized in that: use of a2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative IV as described in claim 1 or 2,
The reaction route is as follows:
preparation of intermediate V:
Dissolving the intermediate IV in mixed acid, heating and refluxing, and performing post-treatment after the reaction is finished to obtain a target product V;
The reaction time is 0.5-10 hours; the mixed acid is at least one of glacial acetic acid, hydrochloric acid, sulfuric acid, trifluoroacetic acid, nitric acid, hydrobromic acid, phosphoric acid, methanesulfonic acid and p-toluenesulfonic acid; the dosage of the mixed acid is 0.5 to 20 times of the mole of the intermediate IV.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311539955.XA CN118146096A (en) | 2023-11-20 | 2023-11-20 | 2, 2-Dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311539955.XA CN118146096A (en) | 2023-11-20 | 2023-11-20 | 2, 2-Dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118146096A true CN118146096A (en) | 2024-06-07 |
Family
ID=91289317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311539955.XA Pending CN118146096A (en) | 2023-11-20 | 2023-11-20 | 2, 2-Dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118146096A (en) |
-
2023
- 2023-11-20 CN CN202311539955.XA patent/CN118146096A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO142258B (en) | PROCEDURE FOR THE PREPARATION OF ALFA-ARYL PROPIONIC ACIDS | |
CN104628572B (en) | The synthetic method of 2 (2,4-dinitrophenoxy of 5 fluorine 2,4) acetic acid esters | |
JPS6333348A (en) | Manufacture of fluorine-substituted organic compound | |
CN109651298B (en) | Preparation method of 2- (2-chlorobenzyl) -2- (1-chloromethyl) oxirane | |
CN113735701B (en) | Preparation method of 8-hydroxy-2,2,14,14-tetramethyl pentadecane diacid | |
CN107428648B (en) | Process for the preparation of compounds such as 3-arylbutyraldehyde useful for the synthesis of medetomidine | |
CN118146096A (en) | 2, 2-Dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative and preparation method thereof | |
CN113185455A (en) | Preparation method of 2-hydroxy-6-trifluoromethylpyridine | |
CN107641067B (en) | Alpha-bromination method of o-diketone | |
CN115784837A (en) | Preparation method of 3-chlorobicyclo [3.2.1] -3-octen-2-ol | |
CN111170846A (en) | Method for preparing 3, 3-dimethyl-2-oxo-butyric acid | |
CN111269190A (en) | Method for synthesizing triazoline thioketone compound by one-pot method | |
CN111348996B (en) | 2-benzoyl malonate compound, and preparation method and application thereof | |
CN114656407A (en) | Method for preparing saflufenacil intermediate | |
US11739038B2 (en) | Method for producing azole derivative, bromohydrin derivative and method for producing same, and method for producing 1-chloro-3-(4-chlorophenoxy)benzene | |
WO2023082149A1 (en) | Process and intermediates for preparation of isofetamid | |
CN116354846B (en) | Synthesis process method of pesticide kresoxim-methyl | |
CN114773324B (en) | Preparation method of difenoconazole | |
CN112409207B (en) | Preparation method of dimoxystrobin | |
JPH01168675A (en) | Production of 1,3-dialkylpyrazole-5-carboxylic acid esters | |
CN112409321B (en) | Method for preparing spiroxamine | |
CN117902980A (en) | Preparation method of high-purity methyl 2-fluoroisobutyrate | |
CN116836085A (en) | Synthesis method of 2-cyano-4, 4-dialkoxy alkyl butyrate | |
JP3073346B2 (en) | Method for producing p-alkoxyneophyl m-phenoxybenzyl ethers | |
CN116425623A (en) | Method for synthesizing 3,5-dichloro-4-methylbenzoic acid by one-pot method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |